Intestinal cytochrome P450 (P450) proteins play an important role in the biotransformation of drugs and may significantly limit their oral absorption and bioavailability. Therefore, we have investigated the amount of P450 proteins via Western blot analysis along the entire intestine of male and female rats. Despite of the use of an inbred rat strain, controlled housing conditions for the animals, and a timed sample preparation, high interindividual differences in the expression of all P450 proteins was observed. CYP3A (135-243 fmol/mg of protein) and CYP2B1 (107-645 fmol/mg of protein) were the most abundant P450 isoforms in the duodenum and jejunum of rat intestine but were present in neither the ileum nor the colon. Compared with CYP2B1 and CYP3A, CYP2D1 (25-71 fmol/mg of protein) and CYP2C6 (3-10 fmol/mg of protein) were only expressed in minor amounts. CYP2C11 could not be identified in the entire rat intestine. In conclusion, this is the first systematic evaluation and quantification of the expression of P450 proteins along the entire length of the intestine in both male and female rats. These data will provide a basis for a better understanding of the extent of intestinal metabolism along the gastrointestinal tract.
Absorption through the gut is a key step in the oral delivery of drugs. The main interface between gut lumen and the bloodstream is an epithelial cell layer consisting of polarized enterocytes controlling the passage of exogenous substances into the portal circulation. Enterocytes have a variety of structural features, including tight junctions reducing paracellular permeability, numerous drug transporters, and a set of metabolic enzymes that may all affect the entry of drugs into the body. The extent to which a drug is absorbed also depends on the intrinsic properties of the compound such as solubility, permeability, efflux or uptake transport properties, and susceptibility to metabolic degradation (Martinez and Amidon, 2002; Benet et al., 2004) .
Although the liver is known as the major site of first-pass extraction, recent studies have indicated that the small intestine also contributes significantly to the first-pass metabolism of many drugs, e.g., cyclosporine (Wu et al., 1995) , nifedipine (Iwao et al., 2002) , midazolam (Paine et al., 1996) , and diltiazem (Iwao et al., 2004) . It is known that several uptake and efflux transporter and P450 isoforms are expressed in the human and rat intestine (van de Kerkhof et al., 2007) . If a drug is a substrate of efflux transporters, it may enter and exit the enterocytes several times, and, with each cycle, small quantities may be metabolized by cytochrome P450 (P450) enzymes localized in the endoplasmic reticulum. The P450 enzymes belong to a superfamily of heme proteins that show a broad substrate specificity, with substrates ranging in size from ethylene (M r 28) to cyclosporine (M r 1201) (Isin and Guengerich, 2007) . Although the liver is regarded as the main organ of drug metabolism, P450 proteins are also expressed in other tissues, e.g., kidney, lung, and the gastrointestinal tract (GIT). Although there is only rudimentary information available on P450 proteins in the human GIT, there is even less information on intestinal P450 expression in rat. Currently, 18 P450 families and 45 P450 subfamilies are known in human, whereas 14 P450 families and 29 P450 subfamilies have been reported in rat (http://cpd.ibmh. msk.su). Of those families, the members of the CYP1, CYP2, and CYP3 gene families play the most important roles in phase I metabolism in liver and intestine. The analysis of P450 in human GIT revealed that CYP2C, CYP1A1, CYP3A4, CYP2D6, and CYP2J2 are expressed (Obach et al., 2006) . Analysis of P450 mRNA expression in rat intestine demonstrated that CYP3A1, 2B1, 2C6, 2C11, 1A1, and 2D1-4 could be detected in significant amounts (Hiroi et al., 1998; Kaminsky and Zhang, 2003; Lindell et al., 2003) . For CYP2C11 and CYP2C12 a gender-dependent protein expression has been published based on liver, with CYP2C11 being exclusively expressed in the male and CYP2C12 in the female rat (Mugford and Kedderis, 1998) . However, CYP1A2, 2A1, 2B2, 2E1, 3A2, and 4A2 mRNA expression could be observed in rat liver but not in the intestine of rats (Hiroi et al., 1998; Kaminsky and Zhang, 2003) . Although many of the CYP P450 isoforms are expressed constitutively, some are expressed as a result of induction, which can occur by use of a normal chow diet as is the case for CYP1A1 (Kaminsky and Zhang, 2003) , suggesting a highly variable expression pattern of P450 proteins along the GIT.
As most of the existing P450 expression data in the rat GIT were obtained by mRNA expression analysis, in particular real-time polymerase chain reaction, there is little information regarding the actual protein expression of P450 proteins. Furthermore, most of the published data represent only selected gut segments and do not yield a comprehensive picture into the P450 expression along the full length of the intestines, which in rat span approximately 90 cm (Iatropoulos, 1986) . Therefore, we have for the first time generated protein expression data for several P450 proteins (CYP3A, 2B1, 2C6, 2C11, 2D1, and 1A1) in full spatial resolution along the entire intestinal tract of female and male rats. As a general expression pattern, CYP3A and CYP2B1 were the predominant P450 proteins in the upper intestine, whereas CYP2D1 and CYP2C6 dominated in the lower intestine and colon. There were high interindividual differences in the expression of all P450 proteins. until use. Protein concentrations were determined with the BCA Assay Protein Kit according to the manufacturer's instructions.
Immunoblotting. Western blot samples were obtained after precipitation of proteins from intestinal homogenates with acetone (1:5 v/v) at Ϫ80°C overnight. Precipitated proteins were resuspended in 8 M urea (10 l/100 g of protein) and denatured for 30 min at 55°C in "sample buffer" (NuPAGE 2X LDS Sample Buffer and NuPAGE 2X Sample Reducing Agent). Samples (100 g of protein/lane) were resolved in NuPAGE Novex 4 -12% Bis-Tris Gradient Gel by SDS gel electrophoresis.
Twenty-five micrograms of liver homogenate was used as a positive control. Proteins were electroblotted onto nitrocellulose membranes for 1 h at room temperature, nonspecific binding sites were blocked with 5% (w/v) nonfat dried milk in TBS-T buffer containing 10 mM Tris-HCl (pH 7.5), 200 mM NaCl, and 0.1% (v/v) Tween 20. Blots were incubated for 1 h at room temperature with either mouse anti-rat CYP2C6 (1:4000), CYP1A1 (1:4000), CYP3A1 (1:2000) , CYP2B1/2 (1:3000), and CYP2C11 (1:4000) monoclonal antibody or rabbit anti-rat CYP2D1 (1:5000) polyclonal antibody. For reference, villin was detected using a polyclonal antibody (1:5000). The specificity of antibodies used was tested beforehand. For the CYP2D1 and CYP3A1 antibody, minor interferences were found with CYP2B1 and CYP3A2, respectively (data not shown). Because several groups have demonstrated that CYP2B2 mRNA is not expressed in the intestine (Kaminsky and Zhang, 2003) , we assume that the Western blot signal of the CYP2B1/2 antibody reflects only the CYP2B1 expression.
After washing, membranes were incubated with peroxidase-conjugated goat anti-rabbit (1:20000) or anti-mouse (1:10000) whole molecule IgG for 1 h and then washed three times with TBS-T. The Western Lightning (PerkinElmer Life and Analytical Sciences, Waltham, MA) chemiluminescent detection system in combination with the ChemiDoc XRS system (Bio-Rad Laboratories, Munich, Germany) was used for band visualization. The Western blots were analyzed densitometrically using Quantity One 1-D Software (BioRad, Laboratories). The P450 signal was normalized with the villin band density.
Intestinal P450 Quantification. Protein levels in intestinal and liver homogenates of CYP2B1, CYP3A, CYP2C6, and CYP2D1 were determined via Western blot analysis using a calibration curve with the respective recombinant rat P450 enzymes (P450 Supersomes). The amounts of P450 Supersomes for calibration were chosen according to the antibody sensitivity and to ensure linearity of the calibration curve. To ensure reproducibility of the quantification, measurement of the amount of P450 protein was repeated three times per segment per animal. As an example, the reproducibilities of the quantification of the CYP3A and CYP2D1 proteins are shown in Table 1 . The P450 amount was determined in intestinal homogenates from six different GIT segments (duodenum, upper jejunum, middle jejunum, lower jejunum, ileum, and colon) and liver from three male rats and just in the intestine from three female rats.
Results

P450 Expression Profile along the Entire Intestine.
The intestines of four male and female rats were prepared for Western blotting as described under Materials and Methods. Typical Western blots are shown in Fig. 1 . For CYP2C11 no signal was detected in any intestinal segment of the rat. The expression profiles of CYP3A, 2B1, 1A1, 2C6, and 2D1 were evaluated 1) along the GIT 2) between female and male rats, and 3) between individual rats of the same sex to extract general expression patterns for intestinal P450 proteins and to assess typical intersubject and gender differences (Fig. 2) .
Despite usage of an inbred rat strain, controlled housing conditions for the animals, and a timed sample preparation, high interindividual differences in the expression of all P450 proteins could be detected. Furthermore, the expression did often not proceed steadily along the intestine, but showed a intermittent profile with alternating peak and valley areas. This intermittent expression was pronounced for CYP3A and CYP2B1. Moreover, both P450 proteins showed a similar expression profile insofar as they had high expression levels in the upper intestine and were hardly detectable in the lower intestine ( Fig. 2A) . In some rats the highest CYP3A expression levels were obtained directly after the pylorus. Other animals showed an increasing expres-sion up to the upper jejunum or even up to the middle of the jejunum. In most of the animals the CYP3A signal disappeared somewhere in the lower intestine, but the exact spot varied considerably. Apart from higher interindividual variations in the female rat, no genderdependent expression profiles were detectable. In female rats CYP2B1 protein expression increased from the pylorus to the upper jejunum and then decreased to relatively low levels at the end of the jejunum ( Fig. 2A) . In contrast, the expression profile of male rats undulated in the upper intestine without any concerted expression peaks among the animals. The following signal decline from the middle of the jejunum was similar in both genders. Compared with female rats, their male counterparts exhibited larger interindividual variation in CYP2B1 expression.
In contrast to CYP3A and CYP2B1 the other P450s investigated (CYP1A1, CYP2D1, and CYP2C6) were present along the whole intestine (Fig. 2, A and B) . The three remaining P450 proteins displayed a flat expression profile with the highest interindividual variations at the endings of the intestine, close to the pylorus, and/or around the cecum and a rather uniform expression in the middle of the jejunum. CYP1A1 revealed either a flat expression along the whole intestine or an expression decrease/increase in the upper/lower gut regions, respectively ( Fig. 2A) . Because of the high variability, no gender difference for CYP1A1 was discernible, but in the female rats a distinct intermittent expression course was detected. The expression profiles of CYP2C6 and CYP2D1 were comparable (Fig. 2B) and were generally flat. Variability occurred mostly in the lower region of the intestine and seldom in the middle part. In male rats, the highest expression was found in the lower parts, in particular in the colon. A tube-shape profile of CYP2D1 expression could be observed in male rats because of an additional variability in the upper part of the intestine, which cannot be seen as clearly in females.
Intestinal and Liver P450 Quantification. The absolute P450 content was determined for four different P450 enzymes in six selected intestinal 3-cm pieces from different segments in three female (Table 2 ) and three male rats (Table 3) . For the male rats, the P450 content of the liver was also calculated (Table 3) . As reference protein and calibration probe, recombinant rat P450 proteins expressed in insect cells (Supersomes) were used. An example of such a Western blot is shown in Fig. 3 . In all intestinal segments examined no gender differences in any of the cytochrome P450 proteins were observed. CYP3A and CYP2B1 were the most abundant P450 isoforms in the duodenum and jejunum of rat intestine but were present in neither the ileum nor the colon. They represented approximately 90% of the sum of the amount of intestinal P450 in duodenum and jejunum of both genders. Whereas CYP2B1 was expressed in relatively constant amounts (332-392 fmol/mg of protein) in male rats, the absolute expression levels in female rats increased from the duodenum to the upper jejunum by 6 times (from 107 to 645 fmol/mg of protein) and dropped back to the initial expression value at the end of the jejunum (98 fmol/mg of protein). In contrast with CYP2B1, CYP3A was expressed in comparable amounts in the jejunum of both genders (135-243 fmol/mg of protein).
Compared with CYP2B1 and CYP3A, CYP2D1 and CYP2C6 were only expressed in minor amounts. Because CYP3A and CYP2B1 were absent in the ileum and colon, CYP2D1 is the predominantly expressed P450 isoform in the lower intestinal region. Although expressed at just 44 to 71 fmol/mg of protein, it represented approximately 90% of the total sum of P450 protein there. In all intestinal segments CYP2C6 contributed only 3 to 10 fmol/mg of protein to the total P450 amount. Therefore, CYP2C6 constituted less than 1% of the total P450 amount and may thus play a minor role in metabolism in the gut.
However, in the liver all enzymes investigated were expressed in very high amounts (Table 3) . The sum of all P450 proteins investi- 
Reproducibility of P450 quantification by Western blot
The data for three independent assays are given. Repeated quantification was done for six segments and two different P450 isoforms (CYP3A and CYP2D1) in one animal. figure. The villin band was taken as a marker protein for enterocytes. CYP3A: two immunoreactive bands were detected after incubation with the CYP3A1 antibody used. The double band was detected in all samples as well as in liver (data not shown), suggesting cross-reactivity with other isoforms of the CYP3A family, which all share a high amino acid sequence identity (70 -97%). For data evaluation, the density of both bands was taken and named CYP3A.
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In contrast with the intestine, the most abundantly expressed P450 isoform in the liver was CYP2C6 at 2373 fmol/mg of protein. The other three P450 enzymes were expressed in comparable amounts of approximately 1500 to 1900 fmol/mg of protein in the liver.
Discussion
The oral route is the most convenient drug administration route. Because intestinal metabolism may have a strong impact on the pharmacokinetics of a drug, the successful development of a drug will rely on comprehensive knowledge of the involvement of metabolic enzymes along the intestine.
Like hepatocytes, enterocytes contain a set of different P450 enzymes that are able to metabolize drugs. Indeed, intestinal drug metabolism has been proposed to play an important role in the biotransformation of drugs and may significantly limit their oral absorption and bioavailability. Although the enzymes involved, the P450 proteins, have attracted a lot of attention in terms of liver metabolism, little information exists regarding their expression in the gut wall, especially in terms of the spatial resolution along the whole length of the intestine.
A number of P450 enzymes have been shown to be constitutively expressed in the GIT of several species. Most of the reported expression analysis was done on the basis of mRNA levels (Yan and Caldwell, 2001 ) in rat or protein levels in humans (Paine et al., 2006) . These rat data, however, are not predictive of actual protein expression and hence functional activity. In this study protein expression data were obtained for the absolute expression of several major P450 proteins along the entire intestine of the rat. The analysis was done by complete segmentation of the entire length of the intestines in both female and male rats to get the full protein expression profile.
It could be demonstrated in this study that a remarkable interindividual variability is characteristic for the expression of the major drug-metabolizing P450 enzymes. This finding is in line with published results from other working groups (Snawder and Lipscomb, 2000) . The same holds true for the efflux transporters in the intestine (MacLean et al., manuscript submitted for publication).
Nevertheless, some typical expression pattern could be discerned. CYP3A and CYP2B1 were expressed predominately in the upper FIG. 2. The figure displays the expression profiles of CYP3A, CYP2B1, and CYP1A1 (A) and CYP2C6 and CYP2D1 (B) along the entire intestine. The relative abundance of each intestinal segment (3 cm) is depicted and assigned to the main intestinal sections (duodenum, jejunum, ileum, and colon) on the x-axis. The data are given for all individual animals tested to give an idea of the variability in P450 expression. The density of each Western blot signal was measured, and the ratio of the P450 signal with the responding villin signal was calculated. To show the dynamics of the expression the ratio of the lowest detectable band was put to 1, and all other signals were compared with it. Samples with no band at all were put to 0.
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at ASPET Journals on April 1, 2017 dmd.aspetjournals.org intestine and were not detectable in the ileum and colon. This finding is consistent with data published by Matsubara et al. (2004) , Takara et al. (2003) , and Takemoto et al. (2003) showing decreasing expression of CYP3A mRNA and decreasing activity along the whole intestine. Even for the human equivalent CYP3A4 declining mRNA expression and activity profile along the human intestine could be demonstrated (Thummel et al., 1997) . The same holds true for CYP2B1, which was also found to be less expressed at lower intestinal regions (Rosenberg, 1991; Takemoto et al., 2003) .
The declining expression of the P450 enzymes at lower intestinal regions may be explained in part by the gut flora. It is known for the human intestine that a minimum of 1000 bacteria species are present in the gut. The duodenum and jejunum have only a few bacteria, whereas ileum and colon contain a large and diverse microbial population (Tlaskalová-Hogenová et al., 2004) . Thus, the increase in the microbial population is inversely proportional to the CYP3A and CYP2B1 protein expression along the gut. The relationship between host and gut flora is mostly harmonious and beneficial for the host. The bacteria, among other things, break down nondigestible carbohydrates and also metabolize bile acids, bilirubin, and cholesterol (Neish, 2002; Mahida, 2004) . The inverse proportionality of the gut microflora with some P450s might support the hypothesis that bacteria take over the function of some intestinal P450s in the distal regions of the intestine. For example, it was shown that isoflavones such as daidzein and glycitein are extensively metabolized by the intestinal microflora of man and rat (Simons et al., 2005; Rafii et al., 2007) . This hypothesis is in accordance with findings of Hooper et al. (2001) who showed decreased CYP2D2 mRNA expression in the ileum of normal mice compared with germ-free mice.
In contrast with CYP3A and CYP2B1, CYP1A1, CYP2C6, and CYP2D1 displayed a generally flat profile with the highest interindividual variations at the endings of the intestine, close to the pylorus and/or around the cecum and a rather uniform expression in the middle of the jejunum. In male rats CYP2C6 and CYP2D1 expression seemed to increase in the lower intestine, but this could not be seen for female animals. To our knowledge no other working group published any mRNA or protein expression profiles for CYP1A1, CYP2C6, and CYP2D1 along the rat intestine. In context with the enteric flora one might assume that bacteria are not able to take over the substrates metabolized by CYP1A1, CYP2C6, and CYP2D1, because those enzymes are still expressed in bacteria-rich areas of the gut. 
P450 amount in the main intestinal section of female rat
Results from three females rats in each case are expressed as means Ϯ S.D. The percentage shown in parentheses refers to the relative contribution of the given P450 to the sum of P450 amount in the respective segment.
Duodenum
Upper In addition, we have not only examined the expression profiles, but we have also investigated the absolute amount and relative contribution of each P450 in the main regions of the rat intestine (duodenum, jejunum, ileum, and colon). The results showed that CYP2B1 and CYP3A represent the major P450 isoforms in the upper intestine of the rat, where they account for approximately 90% of the total amount. CYP2D1 and CYP2C6 are expressed in lower amounts in the gut and play only a minor role in the upper intestine. In the ileum/ colon no CYP3A and CYP2B1 expression could be detected, and, therefore, CYP2D1 dominates this region with 85 to 91% over CYP2C6 (9 -15%). CYP2C11 could not be identified in the entire rat intestine, which is consistent with the findings of other work groups, who found either a very weak signal or no signal at all (de Waziers et al., 1990; Zhang et al., 1996) .
In the liver, however, the P450 isoforms showed a completely different distribution pattern. In contrast to the intestine, CYP2C6 and CYP2D1 are expressed equally or even higher than CYP3A and CYP2B1. CYP2C6 is the major expressed isoform (32%) in the liver of rats, followed by CYP2D1 (25%), CYP2B1 (23%), and CYP3A (20%). This distribution pattern is an accordance with published data by Yan and Caldwell (2001) who demonstrated that the CYP2C family is predominant in the liver (65%), followed by CYP3A2 (14.6%), CYP2B1 (1.9%), and CYP1A1/2 (1.2%), whereas the expression of CYP2D1 was not examined. The low expression level of CYP2B1 is a deviation from our study with one possible explanation being the high inducibility of CYP2B1. Indeed, Stott et al. (2004) showed that P450 expression is dependent on the diet of the animals. They also reported differences depending on the rat strain. Because of the availability of suitable antibodies, we have examined four P450 isoforms, but we cannot exclude the possibility that other P450 proteins are also expressed in remarkable amounts in the intestinal wall. For example, CYP2J3 and other members of the CYP2D family are known to be expressed in rat intestine on the mRNA level (Zeldin et al., 1997; Hiroi et al., 1998) .
In human the P450 intestinal "pie" chart of the proximal jejunum displays CYP3A (82%), followed by CYP2C9 (14%), CYP2C19 (2%), CYP2J2 (1.4%), and CYP2D6 (0.7%) (Paine et al., 2006) . Therefore, CYP3A is one of the most important P450 proteins in rat and human, but in rat represents only 26 to 49% of the sum of the P450 amount in the duodenum and upper jejunum. Interestingly, the human equivalent to the most abundant P450 in rat intestine, CYP2B6, is neither expressed on the mRNA nor on the protein level in the human intestine (Zhang et al., 1999; Paine et al., 2006) . Furthermore, CYP2C9/19 are predominant over CYP2D6 in human but not in rat. CYP2D1 represented 8 to 19% in the rat upper intestine, whereas CYP2C6 represented less than 1% of the sum of the amount of P450. In conclusion, P450 distribution in the human gut is not entirely comparable with that in rat. Furthermore, the corresponding P450 isoform in man often does not possess the same substrate recognition and does not catalyze the same reaction as the related isoform in rat (Guengerich, 1997; da Fonseca et al., 2007) . For example, midazolam, which is a substrate for human CYP3A4/5 and FIG. 3 . Quantification of the absolute P450 amount in intestinal homogenates of one male rat by Western blot analysis. A, example of Western blot. The quantification was done on the basis of a P450 Supersome calibration curve. B, evaluation example for CYP2B1 in a female rat. On each gel were loaded 75-g homogenates of selected intestinal regions: D, duodenum, J1, J2, and J3, upper, middle, and lower jejunum; I, ileum; C, colon; S1-S4, Supersome standard P450 proteins in the four different amounts loaded (CYP2B1 S1: 62.5 fmol, S2: 125 fmol, S3: 250 fmol, S4: 500 fmol; CYP3A1 S1: 3.1 fmol, S2: 6.3 fmol, S3: 12.5 fmol, S4: 25 fmol; CYP2D1 S1: 0.3 fmol, S2: 0.5 fmol, S3: 1 fmol, S4: 2 fmol; and CYP2C6 S1: 0.6 fmol, S2: 1.3 fmol, S3: 2.5 fmol, S4: 5 fmol). (Kotegawa et al., 2002) , is extensively metabolized in the human intestine but not in the rat intestine. The manifestation of these differences between human and rat probably occurred to obtain the best suited P450 enzymes for dietary habits and environment of each species (Lewis et al., 1998) . Taken together, the extensive amount of data in the present study, both in terms of the number of intestinal segments and the number of individuals, clearly show that there is a remarkable variability in the protein expression of intestinal P450 proteins along the GIT of the rat. Although there are some clear gender differences, the intersubject variability in P450 expression within the same sex seems to be larger than that between the sexes, making it difficult to extract a simple pattern for the P450 expression in the GIT. Moreover, the expression of many P450s seems to resemble the shape of waves along the GIT almost as if the expression levels were following the peristaltic movement of food through the gut lumen. Indeed, the animals used were not fasted and the intrasubject expression pattern of the P450 proteins may relate to the individual feeding history with some segments of the GIT having had closer contact to food than others as a result of the typical intermittent motility of the gut after food intake. Thus, not every gut villus may get exposed to food to the same extent. Considering the very short life span of matured enterocytes of approximately 2 days in the rat, their rapid maturation during the migration to the villous tip and their exposure status at the villous tip until they are sloughed off (Iatropoulos, 1986 ) may well result in large local differences in the P450 protein expression of intestinal villi with wave-shaped patterns along the GIT.
The present conclusions are based on very systematically collected protein expression data; however, how very strong differences in expression translate into functional differences in local intestinal metabolism is currently the subject of a subsequent study (manuscript in preparation). Furthermore, protein expression analysis by Western blot has limitations mainly due to availability and selectivity of antibodies used; thus, it is important to verify the results by functional data.
In summary, using a very comprehensive approach we have generated for the first time a full set of consistent data allowing the examination of the expression pattern of P450 proteins more systematically than ever before. The data suggest that compounds that are substrates of CYP2B1 and CYP3A may be more subject to metabolism in the rat intestine than substrates of CYP2C6 and CYP2D1. Once the protein expression data have been confirmed by functional data and sufficient information about the expression and functional contribution of transporters along the intestines is available, these data can be used to generate quantitative scaling factors for intestinal metabolism in the rat.
